Rocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk.

This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Ginger is known for its soothing effects on the stomach, and can effectively relieve nausea. It may also play a role in ...

Grapefruit isn’t the only environmental factor affecting how you respond to your medications. Over 8,600 chemicals are used in commerce in the U.S., and you are exposed to thousands of these chemicals ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

California Sen. Scott Wiener’s SB 40 & SB 41 aim to reduce prescription costs with insulin affordability & PBM reform ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

A small number of patients using GLP-1 weight loss medications have experienced vision loss, although researchers have not ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...